John L. Wallace

1.2k total citations
16 papers, 1.0k citations indexed

About

John L. Wallace is a scholar working on Surgery, Pharmacology and Immunology. According to data from OpenAlex, John L. Wallace has authored 16 papers receiving a total of 1.0k indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Surgery, 8 papers in Pharmacology and 7 papers in Immunology. Recurrent topics in John L. Wallace's work include Inflammatory mediators and NSAID effects (7 papers), Helicobacter pylori-related gastroenterology studies (6 papers) and Mast cells and histamine (3 papers). John L. Wallace is often cited by papers focused on Inflammatory mediators and NSAID effects (7 papers), Helicobacter pylori-related gastroenterology studies (6 papers) and Mast cells and histamine (3 papers). John L. Wallace collaborates with scholars based in Canada, France and United States. John L. Wallace's co-authors include Wallace K. MacNaughton, Gerald P. Morris, Paul L. Beck, Catherine M. Keenan, Cory M. Hogaboam, Élyse Y. Bissonnette, Beth C. Chin, A. Dean Befus, Todd Williamson and David Gall and has published in prestigious journals such as Gastroenterology, The American Journal of Medicine and Journal of Pharmacology and Experimental Therapeutics.

In The Last Decade

John L. Wallace

15 papers receiving 985 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
John L. Wallace Canada 14 312 270 268 192 185 16 1.0k
V. Cosenza Italy 13 195 0.6× 421 1.6× 213 0.8× 79 0.4× 155 0.8× 18 918
Kevin P. Pavlick United States 18 319 1.0× 96 0.4× 351 1.3× 306 1.6× 222 1.2× 20 1.3k
Gary W. Varilek United States 16 194 0.6× 155 0.6× 244 0.9× 240 1.3× 68 0.4× 28 1.2k
Jason M. Hoffman United States 14 316 1.0× 89 0.3× 404 1.5× 222 1.2× 275 1.5× 15 1.3k
I F Stamford United Kingdom 19 291 0.9× 804 3.0× 239 0.9× 68 0.4× 101 0.5× 43 1.3k
Shigeto Mizuno Japan 25 653 2.1× 129 0.5× 363 1.4× 230 1.2× 119 0.6× 75 1.6k
Hua Gan China 20 263 0.8× 87 0.3× 464 1.7× 180 0.9× 117 0.6× 43 1.2k
Niall S. Doherty United States 17 157 0.5× 115 0.4× 345 1.3× 190 1.0× 278 1.5× 35 1.2k
Tatsuya Ohkawara Japan 21 215 0.7× 67 0.2× 338 1.3× 323 1.7× 195 1.1× 39 1.4k
J. B. Meddings Canada 21 444 1.4× 68 0.3× 405 1.5× 89 0.5× 235 1.3× 32 1.4k

Countries citing papers authored by John L. Wallace

Since Specialization
Citations

This map shows the geographic impact of John L. Wallace's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by John L. Wallace with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites John L. Wallace more than expected).

Fields of papers citing papers by John L. Wallace

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by John L. Wallace. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by John L. Wallace. The network helps show where John L. Wallace may publish in the future.

Co-authorship network of co-authors of John L. Wallace

This figure shows the co-authorship network connecting the top 25 collaborators of John L. Wallace. A scholar is included among the top collaborators of John L. Wallace based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with John L. Wallace. John L. Wallace is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

16 of 16 papers shown
1.
Boichot, Elisabeth, John L. Wallace, Noëlla Germain, et al.. (2000). Anti-Inflammatory Activities of a New Series of Selective Phosphodiesterase 4 Inhibitors Derived from 9-Benzyladenine. Journal of Pharmacology and Experimental Therapeutics. 292(2). 647–653. 35 indexed citations
2.
Davies, Neal M. & John L. Wallace. (1996). Selective Inhibitors of Cyclooxygenase-2. Drugs & Aging. 9(6). 406–417. 18 indexed citations
3.
Gall, David, et al.. (1995). Intraluminal pH modulates gastric prostaglandin synthesis. Canadian Journal of Physiology and Pharmacology. 73(1). 130–134. 43 indexed citations
5.
Hogaboam, Cory M., Élyse Y. Bissonnette, Beth C. Chin, A. Dean Befus, & John L. Wallace. (1993). Prostaglandins inhibit inflammatory mediator release from rat mast cells. Gastroenterology. 104(1). 122–129. 107 indexed citations
6.
McCafferty, Donna‐Marie, Paul Kubes, & John L. Wallace. (1993). Inhibition of platelet-activating factor-induced leukocyte adhesion in vivo by a leumedin. European Journal of Pharmacology. 232(2-3). 169–172. 9 indexed citations
7.
Wallace, John L., et al.. (1992). Exacerbation of experimental colitis by nonsteroidal anti-inflammatory drugs is not related to elevated leukotriene B4 synthesis. Gastroenterology. 102(1). 18–27. 142 indexed citations
8.
Hogaboam, Cory M., et al.. (1992). PF-5901 inhibits gastrointestinal platelet-activating factor synthesis in vivo. European Journal of Pharmacology. 216(2). 315–318. 1 indexed citations
9.
Wallace, John L., Catherine M. Keenan, Mercedes Cucala, Kenneth G. Mugridge, & Luca Parente. (1992). Mechanisms underlying the protective effects of interleukin 1 in experimental nonsteroidal anti-inflammatory drug gastropathy. Gastroenterology. 102(4). 1176–1185. 42 indexed citations
10.
Hogaboam, Cory M. & John L. Wallace. (1991). Inhibition of platelet aggregation by capsaicin. An effect unrelated to actions on sensory afferent neurons. European Journal of Pharmacology. 202(1). 129–131. 35 indexed citations
11.
Wallace, John L., Wallace K. MacNaughton, Gerald P. Morris, & Paul L. Beck. (1989). Inhibition of leukotriene synthesis markedly accelerates healing in a rat model of inflammatory bowel disease. Gastroenterology. 96(1). 29–36. 387 indexed citations
12.
Morris, Gerald P., Catherine M. Keenan, Wallace K. MacNaughton, John L. Wallace, & Todd Williamson. (1989). Protection of rat gastric mucosa by sucralfate. The American Journal of Medicine. 86(6). 10–16. 26 indexed citations
13.
Beck, Paul L., Gerald P. Morris, & John L. Wallace. (1989). Reduction of ethanol-induced gastric damage by sodium cromoglycate and FPL-52694. Role of leukotrienes, prostaglandins, and mast cells in the protective mechanism. Canadian Journal of Physiology and Pharmacology. 67(4). 287–293. 26 indexed citations
14.
Wallace, John L. & Wallace K. MacNaughton. (1988). Gastrointestinal damage induced by platelet-activating factor: role of leukotrienes. European Journal of Pharmacology. 151(1). 43–50. 28 indexed citations
15.
Wallace, John L., et al.. (1988). Effects of sucralfate on gastric prostaglandin and leukotriene synthesis: relationship to protective actions. Canadian Journal of Physiology and Pharmacology. 66(5). 666–670. 27 indexed citations
16.
Wallace, John L., et al.. (1987). Gastrointestinal plasma leakage in endotoxic shock. Inhibition by prostaglandin E2 and by a platelet-activating factor antagonist. Canadian Journal of Physiology and Pharmacology. 65(7). 1428–1432. 23 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026